Insmed | INSM - Trade Creditors


Insmed reported $79.91M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Cytokinetics USD 105.62M 83.53M Dec/2025
DBV Technologies USD 39.82M 972K Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
Heron Therapeutics USD 12.02M 20K Sep/2025
Insmed USD 79.91M 316K Dec/2025
Novartis USD 4.56B 49M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025